Aurora Cannabis Inc. (ACB.TO)
CAD 6.11
(-4.83%)
CAD 6.11
(-4.83%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 131.46 Million CAD | 317.49% |
| 2022 | -60.44 Million CAD | -384.78% |
| 2021 | 21.22 Million CAD | 198.46% |
| 2020 | -21.55 Million CAD | 35.72% |
| 2019 | -33.53 Million CAD | -120.99% |
| 2018 | 159.81 Million CAD | 267.23% |
| 2017 | 43.51 Million CAD | 171.05% |
| 2016 | 16.05 Million CAD | 629.08% |
| 2015 | 2.2 Million CAD | 822.53% |
| 2014 | -304.79 Thousand CAD | 0.0% |
| 2013 | - CAD | 0.0% |
| 2012 | - CAD | 0.0% |
| 2011 | - CAD | 0.0% |
| 2010 | - CAD | 0.0% |
| 2009 | - CAD | -100.0% |
| 2008 | 40.83 Thousand CAD | 0.0% |
| 2007 | - CAD | 0.0% |
| 2006 | - CAD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 Q3 | 51.16 Million CAD | 158.38% |
| 2023 Q1 | 34.44 Million CAD | 37.6% |
| 2023 FY | 131.46 Million CAD | 317.49% |
| 2023 Q2 | 19.8 Million CAD | -42.52% |
| 2022 FY | -60.44 Million CAD | -384.78% |
| 2022 Q4 | 25.03 Million CAD | 0.02% |
| 2022 Q2 | -16.17 Million CAD | -846.72% |
| 2022 Q1 | -1.7 Million CAD | -138.91% |
| 2022 Q3 | 25.03 Million CAD | 254.79% |
| 2021 Q4 | 4.39 Million CAD | 130.94% |
| 2021 Q3 | -14.18 Million CAD | -354.28% |
| 2021 Q1 | 25.44 Million CAD | 27.67% |
| 2021 Q2 | 5.58 Million CAD | -78.07% |
| 2021 FY | 21.22 Million CAD | 198.46% |
| 2020 Q1 | 26.62 Million CAD | 118.41% |
| 2020 Q2 | 17.34 Million CAD | -34.83% |
| 2020 Q3 | -85.46 Million CAD | -592.6% |
| 2020 Q4 | 19.93 Million CAD | 123.32% |
| 2020 FY | -21.55 Million CAD | 35.72% |
| 2019 FY | -33.53 Million CAD | -120.99% |
| 2019 Q4 | -144.56 Million CAD | -627.52% |
| 2019 Q3 | 27.4 Million CAD | -8.39% |
| 2019 Q2 | 29.91 Million CAD | -44.3% |
| 2019 Q1 | 53.7 Million CAD | -19.84% |
| 2018 Q4 | 67 Million CAD | 27.33% |
| 2018 FY | 159.81 Million CAD | 267.23% |
| 2018 Q3 | 52.62 Million CAD | 63.72% |
| 2018 Q2 | 32.14 Million CAD | 299.28% |
| 2018 Q1 | 8.05 Million CAD | -60.94% |
| 2017 FY | 43.51 Million CAD | 171.05% |
| 2017 Q4 | 20.6 Million CAD | 170.61% |
| 2017 Q3 | 7.61 Million CAD | 17.41% |
| 2017 Q2 | 6.48 Million CAD | -26.38% |
| 2017 Q1 | 8.81 Million CAD | 50.68% |
| 2016 Q1 | 86.26 Thousand CAD | 102.05% |
| 2016 Q2 | 4.36 Million CAD | 4954.61% |
| 2016 Q3 | 5.76 Million CAD | 32.16% |
| 2016 Q4 | 5.84 Million CAD | 1.46% |
| 2016 FY | 16.05 Million CAD | 629.08% |
| 2015 Q1 | - CAD | 100.0% |
| 2015 Q3 | 4.19 Million CAD | 88.82% |
| 2015 Q2 | 2.21 Million CAD | 0.0% |
| 2015 Q4 | -4.2 Million CAD | -200.42% |
| 2015 FY | 2.2 Million CAD | 822.53% |
| 2014 Q2 | - CAD | 0.0% |
| 2014 Q4 | -18.5 Thousand CAD | 0.0% |
| 2014 Q3 | - CAD | 0.0% |
| 2014 Q1 | - CAD | 0.0% |
| 2014 FY | -304.79 Thousand CAD | 0.0% |
| 2013 FY | - CAD | 0.0% |
| 2013 Q2 | - CAD | 0.0% |
| 2013 Q3 | - CAD | 0.0% |
| 2013 Q4 | - CAD | 0.0% |
| 2013 Q1 | - CAD | 0.0% |
| 2012 Q1 | - CAD | 0.0% |
| 2012 Q3 | - CAD | 0.0% |
| 2012 FY | - CAD | 0.0% |
| 2012 Q2 | - CAD | 0.0% |
| 2012 Q4 | - CAD | 0.0% |
| 2011 Q1 | - CAD | 0.0% |
| 2011 Q4 | - CAD | 0.0% |
| 2011 FY | - CAD | 0.0% |
| 2011 Q2 | - CAD | 0.0% |
| 2011 Q3 | - CAD | 0.0% |
| 2010 Q4 | - CAD | 0.0% |
| 2010 Q1 | - CAD | 0.0% |
| 2010 Q2 | - CAD | 0.0% |
| 2010 FY | - CAD | 0.0% |
| 2010 Q3 | - CAD | 0.0% |
| 2009 FY | - CAD | -100.0% |
| 2009 Q4 | - CAD | 0.0% |
| 2009 Q3 | - CAD | 0.0% |
| 2009 Q2 | - CAD | 0.0% |
| 2009 Q1 | - CAD | -100.0% |
| 2008 Q4 | 40.83 Thousand CAD | 0.0% |
| 2008 Q2 | - CAD | 0.0% |
| 2008 FY | 40.83 Thousand CAD | 0.0% |
| 2008 Q3 | - CAD | 0.0% |
| 2008 Q1 | - CAD | 0.0% |
| 2007 Q3 | - CAD | 0.0% |
| 2007 Q1 | - CAD | 0.0% |
| 2007 Q4 | - CAD | 0.0% |
| 2007 Q2 | - CAD | 0.0% |
| 2007 FY | - CAD | 0.0% |
| 2006 FY | - CAD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Avicanna Inc. | 6.65 Million CAD | -1874.262% |
| Avant Brands Inc. | 12.43 Million CAD | -957.432% |
| Cardiol Therapeutics Inc. | -248.35 Thousand CAD | 53032.294% |
| Crescita Therapeutics Inc. | 10.36 Million CAD | -1168.429% |
| Knight Therapeutics Inc. | 152.65 Million CAD | 13.883% |
| MediPharm Labs Corp. | 5.85 Million CAD | -2145.261% |
| OrganiGram Holdings Inc. | 35.07 Million CAD | -274.816% |
| Canopy Growth Corporation | 80.88 Million CAD | -62.533% |
| Willow Biosciences Inc. | -659 Thousand CAD | 20048.407% |
| Auxly Cannabis Group Inc. | 21.27 Million CAD | -517.85% |